Astma klinikiniai tyrimai Masčusetsas
15 tyrimai dėl Astma ieško dalyvių vietose Masčusetsas.
Miestai Masčusetsas
Oficialus tyrimo tekstas (anglų kalba)
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Worcester
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Boston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07301255A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Brigham and Women's Hospital, Boston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07219173A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Research Site 20, Fall River
Renkami dalyviai3 fazė
Amžius nuo 12 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07359846A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Research Site, Boston
- Research Site, Boston
Renkami dalyviai3 fazė
Amžius nuo 5 iki 11 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06023589A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12119, Boston
- Teva Investigational Site 12182, South Dartmouth
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT06664619A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Boston
Renkami dalyviai2 fazė
Amžius nuo 4 iki 11 · Visoms lytims · Atnaujinta 2026-08-27 · NCT07525375Registry of Asthma Characterization and Recruitment 3 (RACR3)
- Boston Children's Hospital: Department of Immunology, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-21 · NCT05272241Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Boston
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-08-13 · NCT06307665A Study of CDX-622 in Participants With Mild to Moderate Asthma
- Brigham and Women's Hospital, Boston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-02 · NCT07330778Protocol CAUSE-03 / CHEETAH
- Boston University School of Medicine: Pulmonary Center, Boston
- Boston Children's Hospital: Department of Immunology, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-07-01 · NCT06136091Asthma Link Effectiveness Trial
- University of Massachusetts Chan Medical School, Worcester
Renkami dalyviai
Amžius nuo 5 iki 14 · Visoms lytims · Atnaujinta 2026-05-05 · NCT06388460Home Hospital for Suddenly Ill Adults
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-17 · NCT03524222Individualizing Treatment for Asthma in Primary Care (Full Study)
- Reliant Medical Group, Worcester
Renkami dalyviai4 fazė
Amžius nuo 13 iki 75 · Visoms lytims · Atnaujinta 2025-10-29 · NCT07052942Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
- Massachusetts General Hospital, Boston
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2025-09-25 · NCT00595491Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.